Answers are grounded in this paper and cite their sources.
Introduction: the “effort” thrombosis or Paget–schroetter syndrome is an unusual form of upper limb deep venous thrombosis. the current management of this syndrome is surgical and to this date, there is no evidence of the anticoagulant therapy effectiveness. case report: We describe a case of a young Japanese male with pulmonary embolism secondary to Paget–schroetter. the patient was treated with rivaroxaban for the pulmonary embolism and no surgical intervention was done. After a follow-up at 6 and 12 months, there was no recurrence of any thrombotic event. conclusion: We described a clinical scenario in which the use of new oral anticoagulants for the treatment of a pulmonary embolism prevents the recurrence of an upper limb thrombosis secondary to Paget–schroetter syndrome. Even though there is no evidence in favor of using new oral anticoagulants for upper limb thrombosis, the current reports proves its successful use.
No takes yet. Share an insight, caveat, or question.
Mc et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: